Design effective corporate CMC regulatory affairs and compliance strategy for BLA MAA BLA CTA NDA of Biologics ADC bispecific mAbs and Vaccines for US, EU and Asian Markets, including:- Align CMC activities with corporate objective; - Address CMC needs for the specific manufacturing process and product; - Align CMC activities with the ICH/Health Authorities guidance; - Apply risk-based CMC approaches;